Ihorst G - Search Results

1

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

Mathew NR, Baumgartner F, Braun L, O'Sullivan D, Thomas S, Waterhouse M, Müller TA, Hanke K, Taromi S, Apostolova P, Illert AL, Melchinger W, Duquesne S, Schmitt-Graeff A, Osswald L, Yan KL, Weber A, Tugues S, Spath S, Pfeifer D, Follo M, Claus R, Lübbert M, Rummelt C, Bertz H, Wäsch R, Haag J, Schmidts A, Schultheiss M, Bettinger D, Thimme R, Ullrich E, Tanriver Y, Vuong GL, Arnold R, Hemmati P, Wolf D, Ditschkowski M, Jilg C, Wilhelm K, Leiber C, Gerull S, Halter J, Lengerke C, Pabst T, Schroeder T, Kobbe G, Rösler W, Doostkam S, Meckel S, Stabla K, Metzelder SK, Halbach S, Brummer T, Hu Z, Dengjel J, Hackanson B, Schmid C, Holtick U, Scheid C, Spyridonidis A, Stölzel F, Ordemann R, Müller LP, Sicre-de-Fontbrune F, Ihorst G, Kuball J, Ehlert JE, Feger D, Wagner EM, Cahn JY, Schnell J, Kuchenbauer F, Bunjes D, Chakraverty R, Richardson S, Gill S, Kröger N, Ayuk F, Vago L, Ciceri F, Müller AM, Kondo T, Teshima T, Klaeger S, Kuster B, Kim DDH, Weisdorf D, van der Velden W, Dörfel D, Bethge W, Hilgendorf I, Hochhaus A, Andrieux G, Börries M, Busch H, Magenau J, Reddy P, Labopin M, Antin JH, Henden AS, Hill GR, Kennedy GA, Bar M, Sarma A, McLornan D, Mufti G, Oran B, Rezvani K… See abstract for full author list ➔ Mathew NR, et al. Among authors: ihorst g. Nat Med. 2018 Mar;24(3):282-291. doi: 10.1038/nm.4484. Epub 2018 Feb 12. Nat Med. 2018. PMID: 29431743 Free PMC article.

2

Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology.

Müller AM, Ihorst G, Mertelsmann R, Engelhardt M. Müller AM, et al. Among authors: ihorst g. Ann Hematol. 2005 Jan;84(1):1-12. doi: 10.1007/s00277-004-0939-7. Epub 2004 Oct 9. Ann Hematol. 2005. PMID: 15480663 Review.

3

Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation.

Zeiser R, Spyridonidis A, Wäsch R, Ihorst G, Grüllich C, Bertz H, Finke J. Zeiser R, et al. Among authors: ihorst g. Leukemia. 2005 May;19(5):814-21. doi: 10.1038/sj.leu.2403719. Leukemia. 2005. PMID: 15772700

4

Hematopoietic cell transplantation from unrelated donors as an effective therapy for older patients (> or = 60 years) with active myeloid malignancies.

Spyridonidis A, Bertz H, Ihorst G, Grüllich C, Finke J. Spyridonidis A, et al. Among authors: ihorst g. Blood. 2005 May 15;105(10):4147-8. doi: 10.1182/blood-2005-01-0196. Blood. 2005. PMID: 15867422 Free article. No abstract available.

5

Intensive chemotherapy with autologous peripheral blood stem cell transplantation during a 10-year period in 64 patients with germ cell tumor.

Müller AM, Ihorst G, Waller CF, Dölken G, Finke J, Engelhardt M. Müller AM, et al. Among authors: ihorst g. Biol Blood Marrow Transplant. 2006 Mar;12(3):355-65. doi: 10.1016/j.bbmt.2005.11.006. Biol Blood Marrow Transplant. 2006. PMID: 16503505 Free article.

6

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma.

Engelhardt M, Zeiser R, Ihorst G, Finke J, Müller CI. Engelhardt M, et al. Among authors: ihorst g. J Cancer Res Clin Oncol. 2007 Jan;133(1):1-11. doi: 10.1007/s00432-006-0137-1. Epub 2006 Jul 12. J Cancer Res Clin Oncol. 2007. PMID: 16835746 Clinical Trial.

7

High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.

Illerhaus G, Marks R, Ihorst G, Guttenberger R, Ostertag C, Derigs G, Frickhofen N, Feuerhake F, Volk B, Finke J. Illerhaus G, et al. Among authors: ihorst g. J Clin Oncol. 2006 Aug 20;24(24):3865-70. doi: 10.1200/JCO.2006.06.2117. Epub 2006 Jul 24. J Clin Oncol. 2006. PMID: 16864853 Clinical Trial.

8

BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype.

Kaiser S, Hackanson B, Follo M, Mehlhorn A, Geiger K, Ihorst G, Kapp U. Kaiser S, et al. Among authors: ihorst g. Cytotherapy. 2007;9(5):439-50. doi: 10.1080/14653240701358445. Cytotherapy. 2007. PMID: 17786605

9

Characterization of in vitro growth of multiple myeloma cells.

Zlei M, Egert S, Wider D, Ihorst G, Wäsch R, Engelhardt M. Zlei M, et al. Among authors: ihorst g. Exp Hematol. 2007 Oct;35(10):1550-61. doi: 10.1016/j.exphem.2007.06.016. Exp Hematol. 2007. PMID: 17889722 Free article.

10

Reduced-toxicity conditioning with fludarabine, BCNU, and melphalan in allogeneic hematopoietic cell transplantation: particular activity against advanced hematologic malignancies.

Marks R, Potthoff K, Hahn J, Ihorst G, Bertz H, Spyridonidis A, Holler E, Finke JM. Marks R, et al. Among authors: ihorst g. Blood. 2008 Jul 15;112(2):415-25. doi: 10.1182/blood-2007-08-104745. Epub 2008 May 1. Blood. 2008. PMID: 18451310 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters